Comanche Biopharma
Concord
About Comanche Biopharma
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $111.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2024)
- Website: comanchebiopharma.com
- Phone: 617-206-3776
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/comanche-biopharma-41873 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.